No Data
No Data
Mingchen Health: Report for the third quarter of 2024
Mingchen Health (002919.SZ): The net income in the first three quarters was 96.7781 million yuan, a year-on-year decrease of 41.66%.
Mingchen Health (002919.SZ) announced its third quarter report for 2024 on October 29. The company achieved revenue of 0.985 billion yuan in the first three quarters, a decrease of 24.44% year-on-year; the net income attributable to shareholders of the listed company was 96.7781 million yuan, a decrease of 41.66% year-on-year; the net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 95.9264 million yuan, a decrease of 41.15% year-on-year; and the basic earnings per share was 0.36 yuan.
Mingchen Health (002919.SZ): Its death god IP product "Boundary Blade Ring" has now entered the supervision stage.
On October 25th, mingchen health (002919.SZ) stated on the investor interaction platform that the company's death god IP product "Boundary Sword Singing" has entered the supervision stage, with no changes in the collaborating companies such as Word Jump Company, and please refer to the official releases of the collaborating parties or our company for related information.
Mingchen Health (002919.SZ): The operation's gaming section can be adapted to the Hongmeng system.
Gelonghui on September 26th mingchen health (002919.SZ) stated on the investor interaction platform that the company's issuing team has always maintained effective communication with the relevant partners, Hongmeng is an operating system developed independently by local companies, and the gaming segment operated by the company can be adapted.
Mingchen HealthLtd (SZSE:002919) Jumps 12% This Week, Though Earnings Growth Is Still Tracking Behind Five-year Shareholder Returns
Mingchen Health: 2024 Semi-Annual Report Summary
No Data
No Data